-
1
-
-
84884886049
-
-
Tefekli A, Tunc M. Future prospects in the diagnosis and management of localized prostate cancer.Sci World J. 2013; 347263
-
Tefekli A, Tunc M. Future prospects in the diagnosis and management of localized prostate cancer.Sci World J. 2013; 347263
-
-
-
-
2
-
-
84931003444
-
From bench to bedside: immunotherapy for prostate cancer
-
Tse BW, Jovanovic L, Nelson CC, de Souza P, Power CA, Russell PJ. From bench to bedside: immunotherapy for prostate cancer. Biomed Res Int. 2014;981434.
-
Biomed Res Int
, vol.2014
, Issue.98
-
-
Tse, B.W.1
Jovanovic, L.2
Nelson, C.C.3
de Souza, P.4
Power, C.A.5
Russell, P.J.6
-
3
-
-
84884886049
-
-
Tefekli A, Tunc M. Future prospects in the diagnosis and management of localized prostate cancer. Sci World J. 2013; 347263.
-
Tefekli A, Tunc M. Future prospects in the diagnosis and management of localized prostate cancer. Sci World J. 2013; 347263.
-
-
-
-
4
-
-
84866530142
-
Overcoming drug resistance and treating advanced prostate cancer
-
COI: 1:CAS:528:DC%2BC3sXhtlentrs%3D, PID: 22746994
-
Semenas J, Allegrucci C, Boorjian SA, Mongan NP, Persson JL. Overcoming drug resistance and treating advanced prostate cancer. Curr Drug Targets. 2012;13:1308–23.
-
(2012)
Curr Drug Targets
, vol.13
, pp. 1308-1323
-
-
Semenas, J.1
Allegrucci, C.2
Boorjian, S.A.3
Mongan, N.P.4
Persson, J.L.5
-
6
-
-
84911461863
-
Combining oncolytic virotherapy and cytotoxic therapies to fight cancer
-
COI: 1:CAS:528:DC%2BC2cXhvVGgtL3P, PID: 25341928
-
Fillat C, Maliandi MV, Mato-Berciano A, Alemany R1. Combining oncolytic virotherapy and cytotoxic therapies to fight cancer. Curr Pharm Des. 2014;20:6513–21.
-
(2014)
Curr Pharm Des
, vol.20
, pp. 6513-6521
-
-
Fillat, C.1
Maliandi, M.V.2
Mato-Berciano, A.3
Alemany, R.4
-
7
-
-
33751074140
-
Targeting gene-virotherapy of cancer and its prosperity
-
COI: 1:CAS:528:DC%2BD28Xht1Srtb%2FN, PID: 17102812
-
Liu XY. Targeting gene-virotherapy of cancer and its prosperity. Cell Res. 2006;16:879–86.
-
(2006)
Cell Res
, vol.16
, pp. 879-886
-
-
Liu, X.Y.1
-
8
-
-
84934434375
-
Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator
-
COI: 1:CAS:528:DC%2BC3cXhtVSlu7bN, PID: 20694677
-
Notani D1, Limaye AS, Kumar PP, Galande S. Phosphorylation-dependent regulation of SATB1, the higher-order chromatin organizer and global gene regulator. Methods Mol Biol. 2010;647:317–35.
-
(2010)
Methods Mol Biol
, vol.647
, pp. 317-335
-
-
Notani, D.1
Limaye, A.S.2
Kumar, P.P.3
Galande, S.4
-
9
-
-
84899514091
-
Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma
-
PID: 24696710
-
Ye CS, Zhou DN, Yang QQ, Deng YF. Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2014;7:914–22.
-
(2014)
Int J Clin Exp Pathol
, vol.7
, pp. 914-922
-
-
Ye, C.S.1
Zhou, D.N.2
Yang, Q.Q.3
Deng, Y.F.4
-
10
-
-
84894042844
-
Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma
-
COI: 1:CAS:528:DC%2BC2cXitlaqtrs%3D, PID: 24392879
-
Zhang L, Cheng F, He R, Chen H, Liu Y, Sun J. Inhibition of SATB1 by shRNA suppresses the proliferation of cutaneous malignant melanoma. Cancer Biother Radiopharm. 2014;29:77–82.
-
(2014)
Cancer Biother Radiopharm
, vol.29
, pp. 77-82
-
-
Zhang, L.1
Cheng, F.2
He, R.3
Chen, H.4
Liu, Y.5
Sun, J.6
-
11
-
-
84886775826
-
Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells
-
COI: 1:CAS:528:DC%2BC3sXksFOhur0%3D, PID: 23516037
-
Zhang H, Qu S, Li S, Wang Y, Li Y, Wang Y, et al. Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells. Mol Cell Biochem. 2013;378:39–45.
-
(2013)
Mol Cell Biochem
, vol.378
, pp. 39-45
-
-
Zhang, H.1
Qu, S.2
Li, S.3
Wang, Y.4
Li, Y.5
Wang, Y.6
-
12
-
-
84873264989
-
Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells
-
COI: 1:CAS:528:DC%2BC3sXnsFKntLg%3D, PID: 23379909
-
Huang B, Zhou H, Wang X, Liu Z. Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells. Cancer Cell Int. 2013;13:8.
-
(2013)
Cancer Cell Int
, vol.13
, pp. 8
-
-
Huang, B.1
Zhou, H.2
Wang, X.3
Liu, Z.4
-
13
-
-
84876962594
-
SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion
-
COI: 1:CAS:528:DC%2BC3sXosVSgsrc%3D, PID: 23642278
-
Mao L, Yang C, Wang J, Li W, Wen R, Chen J, et al. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion. J Transl Med. 2013;11:111.
-
(2013)
J Transl Med
, vol.11
, pp. 111
-
-
Mao, L.1
Yang, C.2
Wang, J.3
Li, W.4
Wen, R.5
Chen, J.6
-
14
-
-
40749094918
-
SATB1 reprogrammes gene expression to promote breast tumor growth and metastasis
-
COI: 1:CAS:528:DC%2BD1cXjt1Gnurg%3D, PID: 18337816
-
Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumor growth and metastasis. Nature. 2008;452:187–93.
-
(2008)
Nature
, vol.452
, pp. 187-193
-
-
Han, H.J.1
Russo, J.2
Kohwi, Y.3
Kohwi-Shigematsu, T.4
-
15
-
-
84863512872
-
Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer
-
COI: 1:CAS:528:DC%2BC38XhtlOgurzK, PID: 22583549
-
Tu W, Luo M, Wang Z, Yan W, Xia Y, Deng H, et al. Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int. 2012;32:1064–78.
-
(2012)
Liver Int
, vol.32
, pp. 1064-1078
-
-
Tu, W.1
Luo, M.2
Wang, Z.3
Yan, W.4
Xia, Y.5
Deng, H.6
-
16
-
-
0032555716
-
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
-
COI: 1:CAS:528:DyaK1cXlslOrsbw%3D, PID: 9727491
-
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481–90.
-
(1998)
Cell
, vol.94
, pp. 481-490
-
-
Luo, X.1
Budihardjo, I.2
Zou, H.3
Slaughter, C.4
Wang, X.5
-
17
-
-
0032555697
-
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
-
COI: 1:CAS:528:DyaK1cXlslOrsbY%3D, PID: 9727492
-
Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491–501.
-
(1998)
Cell
, vol.94
, pp. 491-501
-
-
Li, H.1
Zhu, H.2
Xu, C.J.3
Yuan, J.4
-
18
-
-
0344188096
-
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
-
COI: 1:CAS:528:DyaK28XmtlCgsrY%3D, PID: 8832876
-
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996;274:373–6.
-
(1996)
Science
, vol.274
, pp. 373-376
-
-
Bischoff, J.R.1
Kirn, D.H.2
Williams, A.3
Heise, C.4
Horn, S.5
Muna, M.6
Sampson-Johannes, A.7
Fattaey, A.8
McCormick, F.9
-
19
-
-
0035346819
-
Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials
-
COI: 1:CAS:528:DC%2BD3MXks1Kmu78%3D, PID: 11727523
-
Kirn D. Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials. Expert Opin Biol Ther. 2001;1:525–38.
-
(2001)
Expert Opin Biol Ther
, vol.1
, pp. 525-538
-
-
Kirn, D.1
-
20
-
-
1842864085
-
An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy
-
COI: 1:CAS:528:DC%2BD2cXivVSitrw%3D, PID: 14728805
-
Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res. 2003;13:481–9.
-
(2003)
Cell Res
, vol.13
, pp. 481-489
-
-
Zhang, Z.L.1
Zou, W.G.2
Luo, C.X.3
Li, B.H.4
Wang, J.H.5
Sun, L.Y.6
-
21
-
-
0037096881
-
An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potentantitumoral efficacy but no toxicity to normal cell
-
COI: 1:CAS:528:DC%2BD38XkslWqsbs%3D, PID: 12067986
-
Tsukuda K1, Wiewrodt R, Molnar-Kimber K, Jovanovic VP, Amin KM. An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potentantitumoral efficacy but no toxicity to normal cell. Cancer Res. 2002;62:3438–47.
-
(2002)
Cancer Res
, vol.62
, pp. 3438-3447
-
-
Tsukuda, K.1
Wiewrodt, R.2
Molnar-Kimber, K.3
Jovanovic, V.P.4
Amin, K.M.5
-
22
-
-
84876523208
-
Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer
-
COI: 1:CAS:528:DC%2BC3sXntVWgt7w%3D, PID: 23613626
-
Fang XF, Hou ZB, Dai XZ, Chen C, Ge J, Shen H, et al. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. World J Gastroenterol. 2013;19:2331–9.
-
(2013)
World J Gastroenterol
, vol.19
, pp. 2331-2339
-
-
Fang, X.F.1
Hou, Z.B.2
Dai, X.Z.3
Chen, C.4
Ge, J.5
Shen, H.6
|